|
1
|
Aggerholm A, Holm MS, Guldberg P, Olesen
LH and Hokland P: Promoter hypermethylation of p15INK4B, HIC1, CDH1
and ER is frequent in myelodysplastic syndrome and predicts poor
prognosis in early-stage patients. Eur J Haematol. 76:23–32. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Krol J, Loedige I and Filipowicz W: The
widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Genet. 11:597–610. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Massillo C, Dalton GN, Farre PL, De Luca P
and De Siervi A: Implications of microRNA dysregulation in the
development of prostate cancer. Reproduction. 154:R81–R97. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhou K, Liu M and Cao Y: New insight into
microRNA functions in cancer: Oncogene-microRNA-tumor suppressor
gene network. Front Mol Biosci. 4:462017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sekar D, Krishnan R, Thirugnanasambantham
K, Rajasekaran B, Islam VI and Sekar P: Significance of microRNA 21
in gastric cancer. Clin Res Hepatol Gastroenterol. 40:538–545.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jang SJ, Choi IS, Park G, Moon DS, Choi
JS, Nam MH, Yoon SY, Choi CH and Kang SH: MicroRNA-205-5p is
upregulated in myelodysplastic syndromes and induces cell
proliferation via PTEN suppression. Leuk Res. 47:172–177. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Song SJ, Ito K, Ala U, Kats L, Webster K,
Sun SM, Jongen-Lavrencic M, Manova-Todorova K, Teruya-Feldstein J,
Avigan DE, et al: The oncogenic microRNA miR-22 targets the TET2
tumor suppressor to promote hematopoietic stem cell self-renewal
and transformation. Cell Stem Cell. 13:87–101. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kuang X, Wei C, Zhang T, Yang Z, Chi J and
Wang L: miR-378 inhibits cell growth and enhances apoptosis in
human myelodysplastic syndromes. Int J Oncol. 49:1921–1930. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pfeffer SR, Yang CH and Pfeffer LM: The
role of miR-21 in cancer. Drug Dev Res. 76:270–277. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Selcuklu SD, Donoghue MT and Spillane C:
miR-21 as a key regulator of oncogenic processes. Biochem Soc
Trans. 37:918–925. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bhagat TD, Zhou L, Sokol L, Kessel R,
Caceres G, Gundabolu K, Tamari R, Gordon S, Mantzaris I, Jodlowski
T, et al: miR-21 mediates hematopoietic suppression in MDS by
activating TGF-β signaling. Blood. 121:2875–2881. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lu Y, Han B, Yu H, Cui Z, Li Z and Wang J:
Berberine regulates the microRNA-21-ITGBeta4-PDCD4 axis and
inhibits colon cancer viability. Oncol Lett. 15:5971–5976.
2018.PubMed/NCBI
|
|
13
|
DeMaria AN: Clinical research in the
United States-a threatened activity. J Am Coll Cardiol. 13:508–510.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Song Y, Zuo Y, Qian XL, Chen ZP, Wang SK,
Song L and Peng LP: Inhibition of MicroRNA-21-5p promotes the
radiation sensitivity of non-small cell lung cancer through HMSH2.
Cell Physiol Biochem. 43:1258–1272. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu L, Xu Q, Li X and Zhang X: MicroRNA-21
regulates the proliferation and apoptosis of cervical cancer cells
via tumor necrosis factor-alpha. Mol Med Rep. 16:4659–4663. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang C and Hu G: Shikonin suppresses
proliferation and induces apoptosis in endometrioid endometrial
cancer cells via modulating miR-106b/PTEN/AKT/mTOR signaling
pathway. Biosci Rep. 38:BSR201715462018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Di Cristofano A and Pandolfi PP: The
multiple roles of PTEN in tumor suppression. Cell. 100:387–390.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang Y, Guo JX and Shao ZQ: miR-21 targets
and inhibits tumor suppressor gene PTEN to promote prostate cancer
cell proliferation and invasion: An experimental study. Asian Pac J
Trop Med. 10:87–91. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zheng P, Chen L, Yuan X, Luo Q, Liu Y, Xie
G, Ma Y and Shen L: Exosomal transfer of tumor-associated
macrophage-derived miR-21 confers cisplatin resistance in gastric
cancer cells. J Exp Clin Cancer Res. 36:532017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang Y, Zhou W, Wu J, Yao L, Xue L, Zhang
Q, Wang Z, Wang X, Dong S, Zhao J and Yin D: Antitumor activity of
nimotuzumab in combination with cisplatin in lung cancer cell line
A549 in vitro. Oncol Lett. 15:5280–5284. 2018.PubMed/NCBI
|
|
22
|
Yang L, Liu H, Long M, Wang X, Lin F, Gao
Z and Zhang H: Peptide SA12 inhibits proliferation of breast cancer
cell lines MCF-7 and MDA-MB-231 through G0/G1 phase cell cycle
arrest. Onco Targets Ther. 11:2409–2417. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu SL, Liu Z, Zhang LD, Zhu HQ, Guo JH,
Zhao M, Wu YL, Liu F and Gao FH: GSK3β-dependent cyclin D1 and
cyclin E1 degradation is indispensable for NVP-BEZ235 induced G0/G1
arrest in neuroblastoma cells. Cell Cycle. 16:2386–2395. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou B, Wang D, Sun G, Mei F, Cui Y and Xu
H: Effect of miR-21 on apoptosis in lung cancer cell through
inhibiting the PI3K/Akt/NF-κB signaling pathway in vitro and in
vivo. Cell Physiol Biochem. 46:999–1008. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang C, Tabatabaei SN, Ruan X and Hardy P:
The dual regulatory role of MiR-181a in breast cancer. Cell Physiol
Biochem. 44:843–856. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Masoudi MS, Mehrabian E and Mirzaei H:
MiR-21: A key player in glioblastoma pathogenesis. J Cell Biochem.
119:1285–1290. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang AJ, Li ZW, Hu MX, Wang SD and Leng M:
Ionic mechanism of noradrenaline-induced membrane potential changes
of neurones in toad dorsal root ganglion. Sheng Li Xue Bao.
41:145–152. 1989.(In Chinese). PubMed/NCBI
|
|
29
|
Echevarria-Vargas IM, Valiyeva F and
Vivas-Mejia PE: Upregulation of miR-21 in cisplatin resistant
ovarian cancer via JNK-1/c-Jun pathway. PLoS One. 9:e970942014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Munch-Petersen HD, Ralfkiaer U, Sjo LD,
Hother C, Asmar F, Nielsen BS, Brown P, Ralfkiaer E and Grønbæk K:
Differential expression of miR-155 and miR-21 in tumor and stroma
cells in diffuse large B-cell lymphoma. Appl Immunohistochem Mol
Morphol. 23:188–195. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
He C, Dong X, Zhai B, Jiang X, Dong D, Li
B, Jiang H, Xu S and Sun X: MiR-21 mediates sorafenib resistance of
hepatocellular carcinoma cells by inhibiting autophagy via the
PTEN/Akt pathway. Oncotarget. 6:28867–28881. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Peralta-Zaragoza O, Deas J, Meneses-Acosta
A, De la O-Gómez F, Fernández-Tilapa G, Gómez-Cerón C,
Benítez-Boijseauneau O, Burguete-García A, Torres-Poveda K,
Bermúdez-Morales VH, et al: Relevance of miR-21 in regulation of
tumor suppressor gene PTEN in human cervical cancer cells. BMC
Cancer. 16:2152016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Reis ST, Pontes-Junior J, Antunes AA,
Dall'Oglio MF, Dip N, Passerotti CC, Rossini GA, Morais DR,
Nesrallah AJ, Piantino C, et al: miR-21 may acts as an oncomir by
targeting RECK, a matrix metalloproteinase regulator, in prostate
cancer. BMC Urol. 12:142012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xue X, Liu Y, Wang Y, Meng M, Wang K, Zang
X, Zhao S, Sun X, Cui L, Pan L and Liu S: MiR-21 and MiR-155
promote non-small cell lung cancer progression by downregulating
SOCS1, SOCS6 and PTEN. Oncotarget. 7:84508–84519. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jurkovicova D, Lukackova R, Magyerkova M,
Kulcsar L, Krivjanska M, Krivjansky V and Chovanec M: microRNA
expression profiling as supportive diagnostic and therapy
prediction tool in chronic myeloid leukemia. Neoplasma. 62:949–958.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zeng W, Dai H, Yan M, Cai X, Luo H, Ke M
and Liu Z: Decitabine-induced changes in human myelodysplastic
syndrome cell line SKM-1 are mediated by FOXO3A activation. J
Immunol Res. 2017:43023202017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li J, Yen C, Liaw D, Podsypanina K, Bose
S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, et al:
PTEN, a putative protein tyrosine phosphatase gene mutated in human
brain, breast and prostate cancer. Science. 275:1943–1947. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wu Y, Song Y, Xiong Y, Wang X, Xu K, Han
B, Bai Y, Li L, Zhang Y and Zhou L: MicroRNA-21 (Mir-21) promotes
cell growth and invasion by repressing tumor suppressor PTEN in
colorectal cancer. Cell Physiol Biochem. 43:945–958. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang WZ, Lin XH, Pu QH, Liu MY, Li L, Wu
LR, Wu QQ, Mao JW, Zhu JY and Jin XB: Targeting miR-21 sensitizes
Ph+ ALL Sup-b15 cells to imatinib-induced apoptosis through
upregulation of PTEN. Biochem Biophys Res Commun. 454:423–428.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lu XX, Cao LY, Chen X, Xiao J, Zou Y and
Chen Q: PTEN inhibits cell proliferation, promotes cell apoptosis
and induces cell cycle arrest via downregulating the PI3K/AKT/hTERT
pathway in lung adenocarcinoma A549 cells. Biomed Res Int.
2016:24768422016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhai Y, Zhang Y, Nan K and Liang X:
Reduced expression levels of PTEN are associated with decreased
sensitivity of HCC827 cells to icotinib. Oncol Lett. 13:3233–3238.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Piovan E, Yu J, Tosello V, Herranz D,
Ambesi-Impiombato A, Da Silva AC, Sanchez-Martin M, Perez-Garcia A,
Rigo I, Castillo M, et al: Direct reversal of glucocorticoid
resistance by AKT inhibition in acute lymphoblastic leukemia.
Cancer Cell. 24:766–776. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Clappier E, Gerby B, Sigaux F, Delord M,
Touzri F, Hernandez L, Ballerini P, Baruchel A, Pflumio F and
Soulier J: Clonal selection in xenografted human T cell acute
lymphoblastic leukemia recapitulates gain of malignancy at relapse.
J Exp Med. 208:653–661. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lien EC, Dibble CC and Toker A: PI3K
signaling in cancer: Beyond AKT. Curr Opin Cell Biol. 45:62–71.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Xue G, Zippelius A, Wicki A, Mandalà M,
Tang F, Massi D and Hemmings BA: Integrated Akt/PKB signaling in
immunomodulation and its potential role in cancer immunotherapy. J
Natl Cancer Inst. 107:djv1712015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang Y, Chen B, Wang Z, Zhang W, Hao K,
Chen Y, Li K, Wang T, Xie Y, Huang Z and Tong X: Marsdenia
tenacissimae extraction (MTE) inhibits the proliferation and
induces the apoptosis of human acute T cell leukemia cells through
inactivating PI3K/AKT/mTOR signaling pathway via PTEN enhancement.
Oncotarget. 7:82851–82863. 2016.PubMed/NCBI
|
|
47
|
Gao YH, Zhang HP, Yang SM, Yang Y, Ma YY,
Zhang XY and Yang YM: Inactivation of Akt by arsenic trioxide
induces cell death via mitochondrial-mediated apoptotic signaling
in SGC-7901 human gastric cancer cells. Oncol Rep. 31:1645–1652.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Gu Y, Li A, Sun H, Li X, Zha H, Zhao J,
Xie J, Zeng Z and Zhou L: BCL6B suppresses proliferation and
migration of colorectal carcinoma cells through inhibition of the
PI3K/AKT signaling pathway. Int J Mol Med. 41:2660–2668.
2018.PubMed/NCBI
|
